Modulation Of Afucosylated Species In A Monoclonal Antibody Composition
Patent No. EP3400241 (titled "Modulation Of Afucosylated Species In A Monoclonal Antibody Composition") was filed by Oncobiologics on Jan 5, 2017. The application was issued on Jul 22, 2020.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3400241
- Application Number
- EP17702444A
- Filing Date
- Jan 5, 2017
- Status
- Revoked
- Apr 29, 2022
- Publication Date
- Jul 22, 2020
- External Links
- Slate, EP3400241B1, Google Patents